SLC2A4 and Insulin resistance: The findings of the present study demonstrated that cirsimaritin-improved insulin resistance is mediated by the activation of the AMPK-GLUT4 pathway in the skeletal and adipose tissues, and by the activation of the AMPK-GLUT2 in the liver.